Cargando…

Hypoparathyroidism: An Uncommon Complication Associated With Immune Checkpoint Inhibitor Therapy

As immune checkpoint inhibitor drugs are being used in the treatment of some cancers, unusual adverse events are being reported, labeled as immune-related adverse events. Various endocrinopathies related to immune-related adverse events have been described, among which hypoparathyroidism is exceedin...

Descripción completa

Detalles Bibliográficos
Autores principales: El Kawkgi, Omar M., Li, Dingfeng, Kotwal, Anupam, Wermers, Robert A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749243/
https://www.ncbi.nlm.nih.gov/pubmed/33367219
http://dx.doi.org/10.1016/j.mayocpiqo.2020.07.006
_version_ 1783625272921161728
author El Kawkgi, Omar M.
Li, Dingfeng
Kotwal, Anupam
Wermers, Robert A.
author_facet El Kawkgi, Omar M.
Li, Dingfeng
Kotwal, Anupam
Wermers, Robert A.
author_sort El Kawkgi, Omar M.
collection PubMed
description As immune checkpoint inhibitor drugs are being used in the treatment of some cancers, unusual adverse events are being reported, labeled as immune-related adverse events. Various endocrinopathies related to immune-related adverse events have been described, among which hypoparathyroidism is exceedingly rare. We report a case of hypoparathyroidism induced by immune checkpoint drugs, highlighting the need for awareness of this emerging complication.
format Online
Article
Text
id pubmed-7749243
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-77492432020-12-22 Hypoparathyroidism: An Uncommon Complication Associated With Immune Checkpoint Inhibitor Therapy El Kawkgi, Omar M. Li, Dingfeng Kotwal, Anupam Wermers, Robert A. Mayo Clin Proc Innov Qual Outcomes Case Report As immune checkpoint inhibitor drugs are being used in the treatment of some cancers, unusual adverse events are being reported, labeled as immune-related adverse events. Various endocrinopathies related to immune-related adverse events have been described, among which hypoparathyroidism is exceedingly rare. We report a case of hypoparathyroidism induced by immune checkpoint drugs, highlighting the need for awareness of this emerging complication. Elsevier 2020-11-03 /pmc/articles/PMC7749243/ /pubmed/33367219 http://dx.doi.org/10.1016/j.mayocpiqo.2020.07.006 Text en © 2020 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
El Kawkgi, Omar M.
Li, Dingfeng
Kotwal, Anupam
Wermers, Robert A.
Hypoparathyroidism: An Uncommon Complication Associated With Immune Checkpoint Inhibitor Therapy
title Hypoparathyroidism: An Uncommon Complication Associated With Immune Checkpoint Inhibitor Therapy
title_full Hypoparathyroidism: An Uncommon Complication Associated With Immune Checkpoint Inhibitor Therapy
title_fullStr Hypoparathyroidism: An Uncommon Complication Associated With Immune Checkpoint Inhibitor Therapy
title_full_unstemmed Hypoparathyroidism: An Uncommon Complication Associated With Immune Checkpoint Inhibitor Therapy
title_short Hypoparathyroidism: An Uncommon Complication Associated With Immune Checkpoint Inhibitor Therapy
title_sort hypoparathyroidism: an uncommon complication associated with immune checkpoint inhibitor therapy
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749243/
https://www.ncbi.nlm.nih.gov/pubmed/33367219
http://dx.doi.org/10.1016/j.mayocpiqo.2020.07.006
work_keys_str_mv AT elkawkgiomarm hypoparathyroidismanuncommoncomplicationassociatedwithimmunecheckpointinhibitortherapy
AT lidingfeng hypoparathyroidismanuncommoncomplicationassociatedwithimmunecheckpointinhibitortherapy
AT kotwalanupam hypoparathyroidismanuncommoncomplicationassociatedwithimmunecheckpointinhibitortherapy
AT wermersroberta hypoparathyroidismanuncommoncomplicationassociatedwithimmunecheckpointinhibitortherapy